Results 11 to 20 of about 27,667 (182)

The facilitatory effect of duloxetine combined with pelvic floor muscle training on the excitability of urethral sphincter motor neurons [PDF]

open access: yes, 2009
INTRODUCTION AND HYPOTHESIS: Aim of this study was to investigate the excitability of sphincter motor neurons under the influence of pelvic floor muscle training (PFMT) and duloxetine.
Boy, S   +4 more
core   +1 more source

Tumor growth activity of duloxetine in Ehrlich carcinoma in mice

open access: yesBMC Research Notes, 2018
Objective The objective of this study was to analyze whether duloxetine influences tumor growth in Ehrlich carcinoma. The mice were administered 5 or 30 mg/kg of duloxetine or saline solution. All animals were inoculated with tumor cells.
Ed Carlos Rey Moura   +6 more
doaj   +1 more source

Efficacy of perioperative duloxetine as a part of multimodal analgesia in laparoscopic colorectal cancer surgeries

open access: yesBMC Anesthesiology, 2023
Background Although laparoscopic surgery provides earlier recovery, less morbidity and hospital stay, however, severe pain is still a problem after it. Duloxetine has been recently used in postoperative pain management. We tested perioperative duloxetine
Diab Fuad Hetta   +5 more
doaj   +1 more source

CYTOTOXIC EFFECTS OF DULOXETINE ON MKN45 AND NIH3T3 CELL LINES AND GENOTOXIC EFFECTS ON HUMAN PERIPHERAL BLOOD LYMPHOCYTES [PDF]

open access: yesArquivos de Gastroenterologia
BACKGROUND: Gastric cancer is the second leading cause of cancer-related death globally. Unfortunately, the survival rate of the gastric cancer patients who underwent chemotherapy following surgery has been less than a half.
Melika HASSANI   +4 more
doaj   +2 more sources

The Potential Antidepressant Action of Duloxetine Co-Administered with the TAAR1 Receptor Agonist SEP-363856 in Mice

open access: yesMolecules, 2022
Here, we explored the possible interaction between duloxetine and SEP-363856 (SEP-856) in depression-related reactions. The results showed that oral administration of duloxetine showed powerful antidepressant-like effects in both the forced swimming test
Xia Ren   +4 more
doaj   +1 more source

Genitofemoral neuralgia : adding to the burden of chronic vulvar pain [PDF]

open access: yes, 2015
The vulva is a particularly common locus of chronic pain with neuropathic characteristics that occurs in women of any age, though most women with neuropathic type chronic vulvar pain will remain undiagnosed even following multiple physician visits. Here,
De Muynck, Martine   +2 more
core   +2 more sources

Quantitative Determination of Duloxetine Hydrochloride in Pharmaceuticals and Urine Using Prepared Ion Selective Membrane Electrode

open access: yesInternational Journal of Electrochemical Science, 2012
A duloxetine ion selective membrane electrode is prepared. The electrode incorporates PVC membrane with duloxetine-silicomolybdate (DLX-SMA) ion pair complex with dioctylphthalate (DOP) as a plasticizer.
Reda A. Ammar   +2 more
doaj   +3 more sources

The therapeutic potential of duloxetine in prostate cancer-related fatigue. [PDF]

open access: yes, 2016
Cancer-related fatigue (CRF) is a common polysymptomatic syndrome with no standard therapy. The authors present the case of a prostate cancer patient in whom, during hormone therapy, disabling CRF and urinary incontinence occurred.
DE SANCTIS, Rita, Vigano', Alessandro
core   +2 more sources

Biocatalysis as Useful Tool in Asymmetric Synthesis: An Assessment of Recently Granted Patents (2014–2019) [PDF]

open access: yes, 2019
The broad interdisciplinary nature of biocatalysis fosters innovation, as different technical fields are interconnected and synergized. A way to depict that innovation is by conducting a survey on patent activities.
Alcántara, Andrés R.   +2 more
core   +3 more sources

Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study. [PDF]

open access: yesPLoS ONE, 2012
This study assessed the effects of the serotonin (5-HT) and norepinephrine (NE) transporter inhibitor duloxetine on the effects of 3,4-methylenedioxy-methamphetamine (MDMA, ecstasy) in vitro and in 16 healthy subjects.
Cédric M Hysek   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy